Part A - Custom synthesis of compounds A1–A13

Usługi doradcze w zakresie działalności gospodarczej, w tym usługi badawcze i eksperymentalno-rozwojowe

Tryb zamówienia	Zapytanie ofertowe
Rodzaj zamówienia	Usługi
Tytuł	Part A - Custom synthesis of compounds A1–A13
Zamawiający	Dostępne dla zalogowanych
Miejsce realizacji	Kraków
Data publikacji	2026-04-20
Data składania ofert	29/04/2026, Godzina 23:59
Dokumenty do pobrania	Dostępne dla zalogowanych
Kod CPV	731000003 Usługi badawcze i eksperymentalno-rozwojowe
Numer przetargu	7108243

<div>
    <h1>REQUEST FOR QUOTATION No. 20 04 2026 S - Building Block Synthesis</h1>

<h2>Załączniki</h2>
    <ul>
            <li><span class="was-link">RFQ 20 04 2026 S.pdf</span></li>
            <li><span class="was-link">Appendix 01 - NDA.pdf</span></li>
            <li><span class="was-link">Appendix 02 - Structures.pdf</span></li>
            <li><span class="was-link">Appendix 03 - Offer Form.docx</span></li>
        </ul>
    
    <h2>Części zamówienia</h2>

<h3>Part A - Custom synthesis of compounds A1–A13</h3>
        <strong>Przedmioty zamówienia</strong>
                    <p>Part A - Custom synthesis of compounds A1–A13<br />
<br />
A description of the subject of the contract is provided in the attached request for quotation no. 20 04 2026 S.<br />
<br />
Due to the necessity of protecting highly sensitive information, detailed chemical structures constituting Appendix 02 are made available only to Bidders who undertake to maintain confidentiality.<br />
In order to obtain access to the confidential information, Bidders are required to either:<br />
•	submit a signed Non Disclosure Agreement (NDA) based on the template attached as Appendix 01, or<br />
•	indicate an NDA currently in force with the Ordering Party that covers the disclosure of confidential technical information relevant to the subject matter of this Request for Quotation.<br />
In the latter case, the Bidder shall provide the reference number and date of the applicable NDA.<br />
Requests for access to confidential information should be sent to tenders@ryvu.com, with the reference number RFQ 20 04 2026 S included in the subject line.<br />
Upon verification that a valid NDA is in place, the Ordering Party shall provide access to the confidential information promptly and on identical terms to all interested Bidders.<br />
</p>

<h2>Kryteria oceny</h2>
                <p>Price net - 100%</p>
                    <h3>Part B - Custom synthesis of compounds B1–B13</h3>
        <strong>Przedmioty zamówienia</strong>
                    <p>Part B - Custom synthesis of compounds B1–B13<br />
<br />
Adescription of the subject of the contract is provided in the attached request for quotation no. 20 04 2026 S.<br />
<br />
Due to the necessity of protecting highly sensitive information, detailed chemical structures constituting Appendix 02 are made available only to Bidders who undertake to maintain confidentiality.<br />
In order to obtain access to the confidential information, Bidders are required to either:<br />
•	submit a signed Non Disclosure Agreement (NDA) based on the template attached as Appendix 01, or<br />
•	indicate an NDA currently in force with the Ordering Party that covers the disclosure of confidential technical information relevant to the subject matter of this Request for Quotation.<br />
In the latter case, the Bidder shall provide the reference number and date of the applicable NDA.<br />
Requests for access to confidential information should be sent to tenders@ryvu.com, with the reference number RFQ 20 04 2026 S included in the subject line.<br />
Upon verification that a valid NDA is in place, the Ordering Party shall provide access to the confidential information promptly and on identical terms to all interested Bidders.<br />
</p>

<h2>Kryteria oceny</h2>
                <p>Price net - 100%</p>
            
        <h2>Warunki zmiany umowy</h2>

<p>Warunki zmiany umowy zostały zamieszone w załączonym zapytaniu ofertowym w wersji PDF.<br />
The terms and conditions of the contract amendment are set out in the attached PDF version of the RFQ.</p>
    </div>